Environmental enrichment cognitive neuroprotection in an experimental model of cerebral ischemia: biochemical and molecular aspects

• Published in: Behavioural brain research 2018-08, Vol.348, p.171-183
• Main Authors: Gonçalves, Lara Vezula, Herlinger, Alice Laschuk, Ferreira, Tamara Andrea Alarcon, Coitinho, Juliana Barbosa, Pires, Rita Gomes Wanderley, Martins-Silva, Cristina
• Format: Article
• Language: English
• Subjects: Cerebral ischemia; Environmental enrichment; Learning and memory; Neuroprotection
• ISSN: 0166-4328; 1872-7549
• DOI: 10.1016/j.bbr.2018.04.023

•Environmental enrichment prevented short-term memory deficit.•Environmental enrichment reduced the infarct volume.•Interleukin 1 beta expression levels were downregulated by environmental enrichment after stroke.•Increase GFAP expression may contribute to cognitive improvement induced by the EE after stroke. Stroke is considered a major cause of global morbidity. Currently, there are no effective treatments for post-stroke cognitive impairment. Enriched environment (EE) has been brought forward as a preconditioning method to induce cerebral tolerance in an ischemic event. However, the subjacent mechanisms involved in this tolerance are not yet clear. Herein we aimed to identify the mechanisms of neuroprotection triggered by EE preconditioning in a murine model of ischemic stroke. In order to do so, C57Bl/6 mice were kept for five weeks either in EE or in standard environment (SC) prior to ischemic injury through bilateral carotid occlusion (BCCAo) or sham surgery. To evaluate cognitive deficits resulting from ischemia, animals were subjected to a set of behavioral test to assess short-term (STM), long-term (LTM) and working memory (WM) performance. Despite no effect of EE having been observed in LTM and WM, EE preconditioning was able to prevent short-term deficits in response to ischemia. This improvement was accompanied by a reduction in the infarct volume in animals following EE pre-exposure. Next, we aimed to analyze the expression of genes involved in cholinergic (M1 and alpha 7 receptors) and glutamatergic (NMDA subunits GluN1, GluN2A, GluN2B and GluN2C) neurotransmission, inflammatory mediators (GFAP and IL-1β) and of the neurotrophin BDNF. Animals tested for STM did not present alterations in the expression of glutamatergic or cholinergic receptors; however, EE was shown to prevent increased expression of IL1-β. On the other hand, in animals submitted to LTM task, EE exposure lead to increased GFAP expression in EE animals that underwent ischemic injury, affecting also the expression of NMDA subunits. In spite of that, no alterations in glutamate content were observed in either group. Altogether, this study suggests that the changes observed in the expression of glutamatergic receptors, the reduction of the inflammatory cytokine IL1-β expression and the increased expression of GFAP in ischemic animals might contribute to the cognitive improvement induced by the EE paradigm.